Oncobiologics competitive analysis

Latest publications and patents of Oncobiologics New

Explore the latest publications and patents granted to Oncobiologics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 1, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Oncobiologics

Jul 22, 2020Modulation Of Afucosylated Species In A Monoclonal Antibody CompositionRevoked

Explore Oncobiologics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 22, 2020Modulation Of Afucosylated Species In A Monoclonal Antibody Composition1

Latest PTAB cases involving Oncobiologics

Discover the latest PTAB cases involving Oncobiologics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Oncobiologics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ONCOBIOLOGICS - 1 - - Non-Active
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB18 - - - Highly Aggressive